Press Release
Back arrow blue Back

Tennessee Oncology and Flatiron Health Partner to Advance the Development of Value-Based Care Products and Services

As part of this partnership, Tennessee Oncology will transition to Flatiron Health’s OncoCloud suite of products including OncoEMR and OncoAnalytics

NEW YORK, NY, July 14, 2016Tennessee Oncology and Flatiron Health today announced a collaboration that will focus on the development of value-based care solutions for cancer care providers to leverage in today’s rapidly evolving reimbursement landscape.

In addition, Tennessee Oncology, one of the largest private, community-based practices in the nation, will utilize Flatiron Health’s OncoEMR®, OncoAnalytics® and new value-based care solution to help ensure successful participation in the Centers for Medicare and Medicaid Services Oncology Care Model (OCM) program. These offerings are part of Flatiron Health’s new OncoCloudTM suite, the industry’s most comprehensive cloud-based software offering for community oncology practices.

“Like us, Flatiron Health is dedicated to helping define the future of cancer care,” said Jeff Patton, MD, CEO of Tennessee Oncology. “We chose them because we needed a long-term partner in innovation. By utilizing their oncology software suite as a foundation, we can combine our expertise and insights to further advance the delivery of high quality care at lower costs to patients.”

Tennessee Oncology and Flatiron Health will focus on leveraging Flatiron’s software and services to enable the development of new value-based care solutions, with a shared commitment to investing heavily in the future of oncology payment reform and technology to improve quality and cost. Tennessee Oncology will also utilize OncoAnalytics to identify further opportunities to enhance the quality and value of care they provide to their patients.

“Oncology care delivery is changing at an incredibly fast pace, especially with new value-based care programs like the Oncology Care Model,” said Robin Shah, Head of Strategic Initiatives, Flatiron Health. “We are very excited about the collaboration opportunities this partnership allows for in order to empower providers across the nation to prepare for the future of value-based care.”

###

About Tennessee Oncology

Tennessee Oncology, PLLC, is one of the nation’s leading teams of cancer care specialists, nationally recognized for improving patient outcomes through clinical trial research and innovative treatments. Its comprehensive range of cancer care services include specialized oncology nursing care, laboratory services, outpatient chemotherapy, PET/CT services and patient education and support services. Tennessee Oncology’s in-practice pharmacy, Park Pharmacy, specializes in oncology and hematology medicines not commonly carried in other local pharmacies. Founded in 1976, Tennessee Oncology is one of the largest, independent, physician-owned oncology practices in the country with more than 80 physicians in 30 locations throughout Tennessee. Visit www.tnoncology.com for more information.

About Flatiron Health, Inc.

Flatiron Health helps the oncology community deliver better, more efficient care by powering an innovative platform to address today’s healthcare challenges. The Flatiron Health OncologyCloud™ platform includes the industry-leading electronic medical record for oncology, advanced analytics, patient portal, and integrated billing management. Backed by Google Ventures, First Round Capital, Roche and others, Flatiron's industry-first technology platform and integrated suite of products deliver comprehensive support for cancer care providers and life science companies. For more information, please visit www.flatiron.com.